News
Novotech a globally recognized full-service clinical research organization (CRO) and scientific ... This press release ...
New research from Omdia reveals that Netflix maintains its leading position in South Korea’s subscription-based online video ...
A man shocked everyone by eating a red envelope that had just been handed to him. This adds another twist to the growing mystery around the so-called "Red Envelope Society." According to witnesses, ...
WNS (Holdings) Limited (NYSE: WNS), a digital-led business transformation and services company, today announced that WNS Procurement has been recognized for the fifth consecutive year as a ‘Leader’ in ...
Visa (NYSE:V), a global leader in digital payments, announced Visa Commercial Integrated Partners, a new program designed to improve connectivity between fintechs and Visa Commercial products through ...
Freo recently acquired its corporate agency license from IRDAI, and now has launched a full-fledged initiative to make health insurance simple, clear, and stress-free—so people can make smarter ...
SDA Bocconi Asia Center, Mumbai Invites Applications for Its Landmark 10th Cohort of the International Executive Master in Business ...
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia ...
Aptos Foundation, dedicated to supporting the development and ecosystem of the high-performance Aptos blockchain, and Hashed Emergent, a Web3 venture capital firm, have announced today a strategic ...
After defining a gTLD, 92% of marketing leaders responded that they could see the potential benefits to gTLDs, with enhanced brand differentiation (46%), improved customer trust (45%), better control ...
Ohana Development, the leading real estate developer renowned for its luxury properties, has ...
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results